NASDAQ:MNMD

Mind Medicine (mindmed) . Subordinate Voting Shares Stock Signals

etoro logo Buy MNMD
*Your capital is at risk
$20.69
+0 (+0%)
At Close: Jun 23, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Mind Medicine (MindMed) Inc. Subordinate Voting Shares

General

Signal Type Signal Value Data
Score 0.000 58 days ( -9.41 %
Last Price $20.69 0 %
Performance History
7 Days
$20.69 $20.69
0%
30 Days
$20.69 $20.69
0%
12 Mos
$6.65 $20.69
211.36%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 34.46
Signal Type Signal Value Importance Data
High / Low N/A Very Low $20.69 - $20.69
Trend - 3 mos 6.08 % High Width: 17.96 %
Pred. range - 3 mos $19.81 - $23.36 Low -4.27 % - 12.92 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Jun 22, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Apr 17, 2026 - 46 days
Short MA 3 mos Buy Low Mar 30, 2026 - 59 days
Long MA 3 mos Sell Medium Mar 27, 2026 - 60 days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 60.24
Signal Type Signal Value Importance Data
Trend - 12 mos 164.83 % Very High Width: 25.09 %
Pred. range - 12 mos $51.28 - $64.15 High 147.85 % - 210.03 %
Short MA 12 mos Buy Very High Mar 30, 2026 - 59 days
Long MA 12 mos Buy Very High Jul 01, 2025 - 246 days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Sell Low Jun 22, 2026 - 2 days
RSI Long Pivot Signal Sell Low Apr 28, 2026 - 39 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT MIND MEDICINE (MINDMED) INC. SUBORDINATE VOTING SHARES
Mind Medicine (MindMed) . Subordinate Voting Shares
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has co...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
OSW
$24.00
17.08% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE